Abstract
Purpose
We sought to estimate the prevalence of potentially inappropriate prescribing (PIP) in the Northern Ireland (NI) population aged ≥70 years, to investigate factors associated with PIP and to calculate total gross cost of PIP.
Methods
A retrospective cross-sectional population study was carried out in those aged ≥70 years in 2009/2010 who were in primary care in NI. Data were extracted from the Enhanced Prescribing Database, which provides details of prescribed and dispensed medications for each individual registered with a general practitioner. Twenty-eight PIP indicators from the Screening Tool of Older Persons potentially inappropriate Prescriptions (STOPP) criteria were applied to these data. PIP prevalence according to individual STOPP criteria and the overall prevalence of PIP were estimated. The relationship between PIP and polypharmacy, age and gender was examined using logistic regression. Gross cost of PIP was ascertained.
Results
The overall prevalence of PIP in the study population (n = 166,108) was 34 %. The most common examples of PIP identified were proton pump inhibitors at maximum therapeutic dose for >8 weeks (17,931 patients, 11 %), non-steroidal anti-inflammatory drugs >3 months (14,545 patients, 9 %) and long-term long-acting benzodiazepines (10,147 patients, 6 %). PIP was strongly associated with polypharmacy, with those receiving seven different medications being fivefold more likely to be exposed to PIP than those on zero to three medications (odds ratio 5.04, 95 % confidence interval 4.84–5.25) The gross cost of PIP was estimated to be €6,098,419
Conclusions
Consistent with other research, the prevalence of PIP was high among the study cohort, increased with polypharmacy and was associated with significant cost.
Similar content being viewed by others
References
O'Mahony D, Gallagher PF (2008) Inappropriate prescribing in the older population: need for new criteria. Age Ageing 37:138–141
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184
Fialova D, Onder G (2009) Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 67:641–645
McLeod P, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 156:385–391
Naugler CT, Brymer C, Stolee P, Arcese ZA (2000) Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 7:103–107
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716–2724
Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 4:891–896
van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC (2005) Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria–a population-based cohort study. Br J Clin Pharmacol 60:137–144
Beers MH (1997) explicit criteria for determining potentially inappropriate medication use by the elderly an update. Arch Intern Med 157:1531–1536
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72–83
Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, Cruz-Jentoft A, Montero B, Lang PO, Michel JP, O'Mahony D (2009) Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 38:603–606
Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293:1348–1358
Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, Cook DG (2008) What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 25:639–706
Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, Mádlová P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O'Mahony D (2011) Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 67:1175–1188
Gallagher P, Barry P, O'Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32:113–121
Klarin I, Wimo A, Fastbom J (2005) The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22:69–82
Hanlon JT, Maher R, Lindblad CI, Ruby CM, Twersky J, Cohen HJ, Schmader KE (2001) Comparison of methods for detecting potential adverse drug events in frail elderly inpatients and outpatients. Am J Health Syst Pharm 58:1622–1626
Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ (2010) Inappropriate prescribing predicts adverse drugevents in older adults. Ann Pharmacother 44:957–963
Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171:1013–1019
Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K (2010) Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 69:543–552
Galway KJ, Murphy AW, O'Reilly D, O'Dowd T, O'Neill C, Shryane E, Steele K, Bury G, Gilliland A, Kelly A (2007) Perceived and reported access to the general practitioner: an international comparison of universal access and mixed private/public systems. Ir Med J 100:494–497
Davis P (2007) Northern Ireland's electronic prescribing and eligibility system. Br J Health Comp 24:12–14
Patterson SM, Hughes C, Kerse N, Cardwell CR (2009) Interventions to improve the appropriate use of polypharmacy for older people (Protocol). Cochrane Database Syst Rev 4:CD008165
Davey P, Ferech M, Ansari F, Muller A, Goossens H, ESAC Project Group (2008) Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother 62:1441–1447
Hughes JD, Tanpurekul W, Keen NC, Ee HC (2009) Reducing the cost of proton pump inhibitors by adopting best practice. Qual Prim Care 17:15–21
Molloy D, Molloy A, O'Loughlin C, Falconer M, Hennessy M (2010) Inppropriate use of proton pump inhibitors. Ir J Med Sci 179:73–75
Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL (2007) Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 83:66–68
Forgacs I, Loganayagam A (2008) Overprescribing proton pump inhibitors. Br Med J 336:2–3
McKay AB, Wall D (2008) Overprescribing PPIs: an old problem. Br Med J 19:109
Choudhry MN, Soran H, Ziglam HM (2008) Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. Q J Med 101:445–448
Yang Y-X, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953
Coté GA, Howden CW (2008) Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep 10:208–214
Fohl AL, Regal RE (2011) Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all? World J Gastrointest Pharmacol Ther 6:17–26
Howden CW, Kahrilas PJ (2010) Editorial: just how “difficult” is it to withdraw PPI treatment? Am J Gastroenterol 105:1538–1540
Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, Swanson KM, Sonnenberg A (2001) Step-down management of gastroesophageal reflux disease. Gastroenterology 121:1095–1100
Inadomi JM, McIntyre L, Bernard L, Fendrick AM (2003) Step down from multiple- to single-dose proton pump inhibitors: a prospective study of patients withheartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 98:1940–1944
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329:15–19
Barkin RL, Beckerman M, Blum SL, Clark FM, Koh EK, Wu DS (2010) Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging 27:775–789
Katz JD, Shah T (2009) Persistent pain in the older adult: what should we do now in light of the 2009 American geriatrics society clinical practice guideline? Pol Arch Med Wewn 119:795–800
Lin J, Zhang W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. Br Med J 329:324–329
De Wilde S, Carey IM, Harris T, Richards N, Victor C, Hilton SR, Cook DG (2007) Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 16:658–667
Tinetti ME (2003) Preventing falls in elderly persons. N Engl J Med 348:42–49
Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D (2004) Benzodiazepine use and hip fractures in the elderly. Who is at greatest risk? Arch Intern Med 164:1567–1572
Haumschild MJ, Karfonta TL, Haumschild MS, Phillips SE (2003) Clinical and economic outcomes of a fall-focused pharmaceutical intervention program. Am J Health Syst Pharm 60:1029–1032
de Gier NA, Gorgels WJ, Lucassen PL, Oude Voshaar R, Mulder J, Zitman F (2011) Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam Pract 28:253–259
Hajar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Psychiatry 5:345–351
Fulton MM, Allen ER (2005) Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17:123–132
Prybys KM (2002) Polypharmacy in the elderly: clinical challenges in emergency practice. Part 1: Overview, etiology and drug interactions. Emerg Med Reports 23:145–153
Gallagher LP (2001) The potential for adverse drug reactions in elderly patients. Appl Nurs Res 14:220–224
Aparasu RR, Mort JR (2004) Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriatr Pharmacother 2:102–111
Liu GG, Christensen DB (2002) The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc 42:847–857
Homemeds.org. (2011) “Medications management model toolkit—unnecessary therapeutic duplication”. Available at: http://www.homemeds.org/images/medialibrary/Protocol___Therapeutic_Duplication.pdf. Accessed 10 Dec 2011
Acknowledgements
We wish to thank the staff at the National Health Service, Business Services Organization (NHS BSO), Information and Registration Unit, for supplying the data from the EPD database and providing technical support, and the Irish Health Research Board for financial support. We wish in particular to acknowledge Maciej Domanski’s contribution (Centre for Public Health and the Centre for Health Improvement, Queen’s University Belfast) in helping with data extraction for this research.
Financial disclosure
The Health Research Board provided financial support for this study: grant reference HRC-2007-1
Sponsor’s role
The sponsor had no role in any aspect of the study apart from providing funding.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bradley, M.C., Fahey, T., Cahir, C. et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 68, 1425–1433 (2012). https://doi.org/10.1007/s00228-012-1249-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1249-y